Transaction DateRecipientSharesTypePriceValue
1st December 2020Joshua Silverman100,000Sale back to the issuer$0.00
1st December 2020Joshua Silverman20,000Grant/award etc.$0.00
2nd November 2020Bay Capital Management Lp Hudson50,000Open or private sale$10.87$543,500.00
16th October 2020Joshua Silverman50,000Open or private purchase$1.09$54,445.00
16th October 2020Bay Capital Management Lp Hudson1,601,100Other acquisition or disposition$10.30$16,491,330.00
15th October 2020Joshua Silverman50,000Open or private purchase$1.07$53,315.00
28th August 2020Bay Capital Management Lp Hudson340,000Other acquisition or disposition$10.77$3,661,800.00
13th July 2020Bay Capital Management Lp Hudson346,857Open or private sale$10.88$3,773,804.16
10th July 2020Bay Capital Management Lp Hudson13,143Open or private sale$10.92$143,521.56
6th July 2020Billy Joe White212,131Exercise of derivative$1.15$243,950.65
Akers Biosciences
Akers Biosciences logo

Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 7/10.

Akers Biosciences, Inc. develops health information technologies. It engages in the developing, manufacturing, and supplying screening and testing products. The company was founded by Raymond Francis Akers, Jr. and Raymond F.Akers, Sr. on March 8, 1989.

Ticker: AKER
Sector: Health Technology
Industry: Medical Specialties
SEC Central Index Key (CIK): 1321834
Employees: 12
Exchange: NASDAQ
Auditor Opinion:

Disclosure Language changes
Red Flags